Effects of endosulfan on the immune function of erythrocytes, and potential protection by testosterone propionate

DOI Web Site Web Site PubMed 被引用文献1件 参考文献20件
  • Zhao Yan-Zhi
    Department of Physiology, Yanjing Medical College, Capital Medical University, China Department of Health Toxicology and Health Chemistry, Public Health College, Capital Medical University, China
  • Jia Jing
    Department of Health Toxicology and Health Chemistry, Public Health College, Capital Medical University, China
  • Li Yan-Bo
    Department of Health Toxicology and Health Chemistry, Public Health College, Capital Medical University, China Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, China
  • Guo Cai-Xia
    Department of Health Toxicology and Health Chemistry, Public Health College, Capital Medical University, China Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, China
  • Zhou Xian-Qing
    Department of Health Toxicology and Health Chemistry, Public Health College, Capital Medical University, China Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, China
  • Sun Zhi-Wei
    Department of Health Toxicology and Health Chemistry, Public Health College, Capital Medical University, China Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, China

この論文をさがす

説明

While the immunotoxicity of endosulfan has been studied, little is known about its influence on immune function associated with erythrocytes (RBC). The aim of this study was to investigate the possible effects of endosulfan, and any possible mitigation by testosterone propionate (TP), on erythrocyte immune function in a mouse model. To this end, rosette formation [as erythrocyte C3b receptor(E-C3bR) and erythrocyte immune complexes (E-IC)], as well as measures of the erythrocyte C3b receptor rosette-forming enhancing rate (RFER; reflecting immunoenhancing factor activity) and C3b receptor rosette-forming inhibitory rate (RFIR; reflecting immunosuppressive factor activity) were performed. The effects of RBC on regulating NK cell function or T-cell adherence were also analyzed. Lastly, to begin to assess potential mechanisms by which endosulfan could impact on the measured endpoints, CD35, CD58, and CD59 expression on RBC was evaluated; expression/mRNA levels of complement receptor I-related gene/protein y (Crry) on cells/splenic tissues was also assessed. The data show that E-C3bR rosette ratios decreased, and those of E-IC increased, due to endosulfan treatment. In these hosts, RFER (i.e., immunoenhancing factor in plasma) was decreased, but RFIR (i.e., immunosuppressive factor) was unchanged.There were no clear effects from endosulfan on RBC regulatory function against NK or T-cells. Lastly, Crry mRNA levels in tissues/cells from these mice were significantly decreased; however, CD59 and CD58 expression levels were unaffected. The data also show that TP co-treatment reversed or mitigated effects of endosulfan on each endpoint, in part, by two possible mechanisms; the TP may be increasing the activity of the innate immune enhancing factor, or, an anti-oxidant effect of TP might help to protect membrane structures and increase Crry stability on the RBC.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (20)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ